Contents
xiii
29.17
Dopamine Receptor Antagonists
(First-Generation Antipsychotics)
972
29.18
Lamotrigine
981
29.19
Lithium
983
29.20
Melatonin Agonists: Ramelteon and
Melatonin
991
29.21
Mirtazapine
993
29.22
Monoamine Oxidase Inhibitors
994
29.23
Nefazodone and Trazodone
997
29.24
Opioid Receptor Agonists
1000
29.25
Opioid Receptor Antagonists:
Naltrexone, Nalmefene, and
Naloxone
1004
29.26
Phosphodiesterase-5 Inhibitors
1008
29.27
Selective Serotonin–Norepinephrine
Reuptake Inhibitors
1010
29.28
Selective Serotonin Reuptake
Inhibitors
1013
29.29
Serotonin–Dopamine Antagonists
and Similarly Acting Drugs
(Second-Generation or Atypical
Antipsychotics)
1023
29.30
Stimulant Drugs and Atomoxetine 1033
29.31
Thyroid Hormones
1039
29.32
Tricyclics and Tetracyclics
1040
29.33
Valproate
1045
29.34
Nutritional Supplements and
Medical Foods
1049
29.35
Weight Loss Drugs
1060
30
Brain Stimulation Methods
1065
30.1
Electroconvulsive Therapy
1065
30.2
Other Brain Stimulation Methods
1072
30.3
Neurosurgical Treatments and
Deep Brain Stimulation
1077
31.1
Introduction: Infant, Child, and
Adolescent Development
1082
31.2
Assessment, Examination, and
Psychological Testing
1107
31.3
Intellectual Disability
1118
31.4
Communication Disorders
1137
31.4a
Language Disorder
1137
31.4b
Speech Sound Disorder
1144
31.4c
Child-Onset Fluency
Disorder (Stuttering)
1147
31.4d
Social (Pragmatic)
Communication
Disorder
1149
31.4e
Unspecified
Communication Disorder 1151
31.5
Autism Spectrum Disorder
1152
31.6
Attention Deficit/Hyperactivity
Disorder
1169
31.7
Specific Learning Disorder
1181
31.8
Motor Disorders
1190
31.8a
Developmental
Coordination Disorder
1190
31.8b
Stereotypic Movement
Disorder
1194
31.8c
Tourette’s Disorder
1197
31.8d
Persistent (Chronic) Motor
or Vocal Tic Disorder
1205
31.9
Feeding and Eating Disorders of
Infancy or Early Childhood
1205
31.9a
Pica
1206
31.9b
Rumination Disorder
1207
31.9c
Avoidant/Restrictive Food
Intake Disorder
1209
31.10
Elimination Disorders
1211
31.10a
Encopresis
1212
31.10b
Enuresis
1214
31.11
Trauma- and Stressor-Related
Disorders in Children
1216
31.11a
Reactive Attachment
Disorder and Disinhibited
Social Engagement
Disorder
1217
31.11b
Posttraumatic Stress
Disorder of Infancy,
Childhood, and
Adolescence
1221
31.12
Mood Disorders and Suicide in
Children and Adolescents
1226
31.12a
Depressive Disorders and
Suicide in Children and
Adolescents
1226
31.12b
Early-Onset Bipolar
Disorder
1236
31.12c
Disruptive Mood
Dysregulation Disorder 1242
31.12d
Oppositional Defiant
Disorder
1244
31.12e
Conduct Disorder
1247
31.13
Anxiety Disorders of Infancy,
Childhood, and Adolescence
1253
